Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jun;30(2):165-76.
doi: 10.1097/YCT.0000000000000137.

Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy

Affiliations
Review

Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy

Shawn M McClintock et al. J ECT. 2014 Jun.

Abstract

For many patients with neuropsychiatric illnesses, standard psychiatric treatments with mono or combination pharmacotherapy, psychotherapy, and transcranial magnetic stimulation are ineffective. For these patients with treatment-resistant neuropsychiatric illnesses, a main therapeutic option is electroconvulsive therapy (ECT). Decades of research have found ECT to be highly effective; however, it can also result in adverse neurocognitive effects. Specifically, ECT results in disorientation after each session, anterograde amnesia for recently learned information, and retrograde amnesia for previously learned information. Unfortunately, the neurocognitive effects and underlying mechanisms of action of ECT remain poorly understood. The purpose of this paper was to synthesize the multiple moderating and mediating factors that are thought to underlie the neurocognitive effects of ECT into a coherent model. Such factors include demographic and neuropsychological characteristics, neuropsychiatric symptoms, ECT technical parameters, and ECT-associated neurophysiological changes. Future research is warranted to evaluate and test this model, so that these findings may support the development of more refined clinical seizure therapy delivery approaches and efficacious cognitive remediation strategies to improve the use of this important and widely used intervention tool for neuropsychiatric diseases.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Conceptual Model of How Electroconvulsive Therapy Affects Neurocognitive Function
This figure shows the conceptual model of the relationship among neuropsychiatric disease, electroconvulsive therapy, altered cortical excitability/neural oscillations, demographic factors, and neurocognitive function. ECT=Electroconvulsive Therapy
Figure 2
Figure 2. Proposed Causal Model of How Electroconvulsive Therapy Affects Memory Function
This figure shows a causal model of how electroconvulsive therapy negatively impacts memory function in patients with major depressive disorder through its intermediate alterations in cortical excitability and disruption of long-term potentiation (LTP). ECT=Electroconvulsive Therapy

References

    1. Rush AJ, et al. Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression. New England Journal of Medicine. 2006;354(12):1231–1242. - PubMed
    1. Sachs GS, et al. Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression. New England Journal of Medicine. 2007;356(17):1711–1722. - PubMed
    1. Lieberman JA, et al. Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia. New England Journal of Medicine. 2005;353(12):1209–1223. - PubMed
    1. Lisanby SH. Electroconvulsive Therapy for Depression. New England Journal of Medicine. 2007;357:1939–1945. - PubMed
    1. Weiner RD, et al. Electroconvulsive therapy device classification: Response to the FDA advisory panel hearing and recommendations. Journal of Clinical Psychiatry. 2013;74(1):38–42. - PubMed

Supplemental References

    1. Hickie I, et al. Prediction of ECT response: validation of a refined sign-based (CORE) system for defining melancholia. The British Journal of Psychiatry. 1996;169(1):68–74. - PubMed
    1. Petrides G, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT. 2001;17(4):244–53. - PubMed
    1. Nuechterlein KH, et al. Individual placement and support for individuals with recent-onset schizophrenia: integrating supported education and supported employment. Psychiatric Rehabilitation Journal. 2008;31(4):340–349. - PubMed
    1. Corcoran C, et al. Trajectory to a first episode of psychosis: a qualitative research study with families. Early Intervention in Psychiatry. 2007;1(4):308–315. - PMC - PubMed
    1. Kurtz MM. Neurocognitive impairment across the lifespan in schizophrenia: an update. Schizophrenia Research. 2005;74(1):15–26. - PubMed

Publication types

MeSH terms